Pennington, NJ, United States of America

Harold N Weller, Iii


Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 216(Granted Patents)


Company Filing History:


Years Active: 1984-2000

Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Harold N Weller, III

Introduction: Harold N Weller, III, based in Pennington, NJ, has made significant strides in the field of pharmaceuticals, holding an impressive portfolio of 20 patents. His work primarily focuses on novel compounds that address critical health conditions, showcasing his commitment to innovation in medicine.

Latest Patents: Among his latest patents are the Quinazolinone inhibitors of cGMP phosphodiesterase, which are novel quinazolinone compounds designed to treat cGMP-associated conditions such as erectile dysfunction. This patent also includes pharmaceutical compositions containing these compounds. Another noteworthy patent is for non-peptidic angiotensin-II-receptor-antagonists, which are innovative compounds that inhibit the action of angiotensin II, making them valuable as antihypertensive agents.

Career Highlights: Harold has built a distinguished career while working for renowned companies such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His expertise and innovative mindset have led to advancements that greatly contribute to the field of pharmaceuticals.

Collaborations: Throughout his career, Harold has collaborated with esteemed colleagues, including Eric M Gordon and Denis E Ryono. These partnerships have enhanced the research and development of the innovative compounds he has patented.

Conclusion: Harold N Weller, III stands out as a prominent inventor in the pharmaceutical industry, with a strong emphasis on developing innovative treatments for various health conditions. His 20 patents reflect his dedication to improving human health through groundbreaking research and collaboration with other talented professionals in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…